Your browser does not support JavaScript or it may be disabled!

NewsApp (Free)

Read news as it happens
Download NewsApp
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News Home   |   Images Home
 rediff News App

About 1333 results for "equity research"

CY13 Sensex target at 20700; bet on NBFCs, pvt banks: HSBC

CY13 Sensex target at 20700; bet on NBFCs, pvt banks: HSBC

Jitendra Sriram, MD Head of Research, HSBC India is more cautions on Indian equities, compared with other Asian markets, given expensive valuation. Money Control, 6 days ago
Volatile week for global stock markets Equitymaster.com, 18 hours ago
Sensex at 20k: Time to get cautious? Equitymaster.com, 2 weeks ago

880 images for equity research

Proactive Investors USA, 1 week ago
Money Life, 1 week ago
Value Walk, 1 day ago
Wall Street Transcript, 13 hours ago
MSN Money, 1 day ago
Technology Tell, 4 days ago
MSN Money, 1 week ago
MSN Money, 1 week ago
MSN Money, 1 week ago
Professional Pensions, 1 month ago

Risk-off mode in equities impacting rupee: HSBC

In an interview with ET Now, Paul Mackel, Managing Director-Head of Asian Currency Research, HSBC, shares his outlook for currency. Excerpts: ET Now: The rupee has been on a weak trend and is down nearly 3% in May. Besides the strength in dollar, ...
 Economic Times1 day ago
Money Control

UBS sees Nifty in 5500-6400 range; bullish on IT, telecom

Gautam Chhaochharia, head of mid-cap research, UBS India is positive on the Indian equity market and expects Nifty to hover in the broad range of 5500-6400 this year.
 Money Control3 weeks ago Stock markets continue to slide  Equitymaster.com2 days ago Do we need a better market regulator?  Equitymaster.com3 days ago Indian share markets stay afloat  Equitymaster.com3 days ago
[x]  
Business Today India

Reliance Industries a good long term bet: Chakraborty

Reliance Industries is a good long term bet, says Nandan Chakraborty, MD - Institutional Equity Research, Axis Capital.
 Money Control1 month ago Quantum Long Term Equity Fund: On the high road  Business Today India4 days ago TCS, HCL Tech look good: Chakraborty  Money Control1 month ago
Money Control

Brokers' call: Exide gets Nomuras buy rating

Nomura Equity Research has upgraded Exide Industries to buy rating with a target price of Rs 151.
 Economic Times2 months ago Buy Helios; target of Rs 69: BP Equities  Money Control3 days ago Brokers Call: Nomura upgrades Exide to buy  Economic Times2 months ago

Crisil Research assigns IPO grade 5/5 to Just Dial

This indicates that the fundamentals of the IPO are strong relative to the other listed equity securities in India. The grade is not a recommendation to buy, sell or hold the graded instrument, or a comment on the graded instrument's future market price or ...
 Economic Times1 week ago CRISIL revises Shriram City`s fundamental grade to 4/5  Money Control1 month ago CRISIL revises JBF Industries fundamental grade to 2/5  Myiris2 months ago
Money Control

Market to remain volatile ahead of expiry: Emkay

Emkay Global Financial Services has come out with its technical report on Indian equity markets. The research firm feels the market will remain volatile ahead of expiry. According to him, one needs to trade with the strict stop loss.
 Money Control1 month ago Gold comes out of darkness: Dani Commodities  Money Control1 month ago Gold may decline further on strong equity markets: Emkay  Money Control1 month ago See volatile trade ahead of FO expiry: R K Global  Money Control2 months ago

Nifty will face resistance near 6040: Magnum

Magnum Research in a morning report on equity market says the Nifty will face resistance near 6,040 levels. The brokerage house sees support near the 5,930 mark.
 Money Control2 weeks ago Nifty has immediate resistance at 5850: Nirmal Bang  Money Control1 month ago

Bullish on Lupin among largecap pharma stocks: Edelweiss

In an interview to CNBC-TV18, Manoj Garg, VP, Institutional Equities - Research, Edelweiss Securities shares his outlook on the pharmaceutical companies that reported their fourth quarter numbers recently.
 Money Control2 weeks ago
Money Control

Nomura "overweight" on rate-cyclicals, defensives

Reuters Market Eye - Nomura Equity Research is "overweight" on rate cyclicals and defensive growth plays but remains "underweight" on domestic growth cyclicals.
 Business Standard3 weeks ago Nomura 'overweight' on rate-cyclicals, defensives  Money Control3 weeks ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts
WidgetGet Realtime news on your homepage & get your members hooked.Add Realtime Widget
 rediff News App

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - equity research
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
    
Widget
Get Realtime News on your webpage & get your members hooked!
 
More     Less